Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole
Identifieur interne : 003265 ( Main/Exploration ); précédent : 003264; suivant : 003266Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole
Auteurs : Christopher J. D. Sinclair [Canada] ; Ljiljana Krizanac-Bengez [États-Unis] ; Kathë A. Stanness [États-Unis] ; Damir Janigro [États-Unis] ; Fiona E. Parkinson [Canada]Source :
- Brain Research [ 0006-8993 ] ; 2001.
English descriptors
- KwdEn :
- Adenosine (antagonists & inhibitors), Adenosine (metabolism), Adenosine transport, Animals, Blood-Brain Barrier (physiology), Capillary Permeability (drug effects), Carrier Proteins (antagonists & inhibitors), Cattle, Cells, Cultured, Cellular and molecular biology, Dipyridamole, Dipyridamole (pharmacology), Dynamic in vitro blood–brain barrier, Models, Biological.
- MESH :
- chemical , antagonists & inhibitors : Adenosine, Carrier Proteins.
- chemical , metabolism : Adenosine.
- drug effects : Capillary Permeability.
- chemical , pharmacology : Dipyridamole.
- physiology : Blood-Brain Barrier.
- Animals, Cattle, Cells, Cultured, Models, Biological.
Abstract
Adenosine is an inhibitory neuromodulator in the central nervous system and has been reported to have neuroprotective properties. Using a dynamic in vitro blood–brain barrier, we investigated the hypothesis that inhibition of adenosine transporters on the lumenal side of the blood–brain barrier may decrease the loss of adenosine from the brain. Our results indicate that lumenal administration of dipyridamole, a nucleoside transport inhibitor, can inhibit adenosine permeation from the extracapillary space into the lumen.
Url:
DOI: 10.1016/S0006-8993(01)02175-8
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000730
- to stream Istex, to step Curation: 000730
- to stream Istex, to step Checkpoint: 001094
- to stream Main, to step Merge: 003747
- to stream PubMed, to step Corpus: 001574
- to stream PubMed, to step Curation: 001574
- to stream PubMed, to step Checkpoint: 001574
- to stream Ncbi, to step Merge: 000154
- to stream Ncbi, to step Curation: 000154
- to stream Ncbi, to step Checkpoint: 000154
- to stream Main, to step Merge: 003600
- to stream Main, to step Curation: 003265
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole</title>
<author><name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D." last="Sinclair">Christopher J. D. Sinclair</name>
</author>
<author><name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
</author>
<author><name sortKey="Stanness, Kathe A" sort="Stanness, Kathe A" uniqKey="Stanness K" first="Kathë A." last="Stanness">Kathë A. Stanness</name>
</author>
<author><name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
</author>
<author><name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:AEDC0F477A53B2E132B34A9E0AFA1BB767CE4611</idno>
<date when="2001" year="2001">2001</date>
<idno type="doi">10.1016/S0006-8993(01)02175-8</idno>
<idno type="url">https://api-v5.istex.fr/document/AEDC0F477A53B2E132B34A9E0AFA1BB767CE4611/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000730</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000730</idno>
<idno type="wicri:Area/Istex/Curation">000730</idno>
<idno type="wicri:Area/Istex/Checkpoint">001094</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001094</idno>
<idno type="wicri:doubleKey">0006-8993:2001:Sinclair C:adenosine:permeation:of</idno>
<idno type="wicri:Area/Main/Merge">003747</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:11292455</idno>
<idno type="wicri:Area/PubMed/Corpus">001574</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001574</idno>
<idno type="wicri:Area/PubMed/Curation">001574</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001574</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001574</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001574</idno>
<idno type="wicri:Area/Ncbi/Merge">000154</idno>
<idno type="wicri:Area/Ncbi/Curation">000154</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000154</idno>
<idno type="wicri:doubleKey">0006-8993:2001:Sinclair C:adenosine:permeation:of</idno>
<idno type="wicri:Area/Main/Merge">003600</idno>
<idno type="wicri:Area/Main/Curation">003265</idno>
<idno type="wicri:Area/Main/Exploration">003265</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole</title>
<author><name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D." last="Sinclair">Christopher J. D. Sinclair</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, 753 McDermot Avenue, Winnipeg</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cerebrovascular Research Unit, Cleveland Clinic Foundation, Cleveland, OH 444195</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Stanness, Kathe A" sort="Stanness, Kathe A" uniqKey="Stanness K" first="Kathë A." last="Stanness">Kathë A. Stanness</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cerebrovascular Research Unit, Cleveland Clinic Foundation, Cleveland, OH 444195</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cerebrovascular Research Unit, Cleveland Clinic Foundation, Cleveland, OH 444195</wicri:regionArea>
<placeName><region type="state">Ohio</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
<affiliation wicri:level="4"><country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, University of Manitoba, 753 McDermot Avenue, Winnipeg</wicri:regionArea>
<orgName type="university">Université du Manitoba</orgName>
<placeName><settlement type="city">Winnipeg</settlement>
<region type="state">Manitoba</region>
</placeName>
</affiliation>
<affiliation></affiliation>
<affiliation wicri:level="1"><country wicri:rule="url">Canada</country>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Brain Research</title>
<title level="j" type="abbrev">BRES</title>
<idno type="ISSN">0006-8993</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="2001">2001</date>
<biblScope unit="volume">898</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="122">122</biblScope>
<biblScope unit="page" to="125">125</biblScope>
</imprint>
<idno type="ISSN">0006-8993</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0006-8993</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenosine (antagonists & inhibitors)</term>
<term>Adenosine (metabolism)</term>
<term>Adenosine transport</term>
<term>Animals</term>
<term>Blood-Brain Barrier (physiology)</term>
<term>Capillary Permeability (drug effects)</term>
<term>Carrier Proteins (antagonists & inhibitors)</term>
<term>Cattle</term>
<term>Cells, Cultured</term>
<term>Cellular and molecular biology</term>
<term>Dipyridamole</term>
<term>Dipyridamole (pharmacology)</term>
<term>Dynamic in vitro blood–brain barrier</term>
<term>Models, Biological</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Adenosine</term>
<term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Adenosine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Capillary Permeability</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Dipyridamole</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Blood-Brain Barrier</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Cattle</term>
<term>Cells, Cultured</term>
<term>Models, Biological</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Adenosine is an inhibitory neuromodulator in the central nervous system and has been reported to have neuroprotective properties. Using a dynamic in vitro blood–brain barrier, we investigated the hypothesis that inhibition of adenosine transporters on the lumenal side of the blood–brain barrier may decrease the loss of adenosine from the brain. Our results indicate that lumenal administration of dipyridamole, a nucleoside transport inhibitor, can inhibit adenosine permeation from the extracapillary space into the lumen.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Manitoba</li>
<li>Ohio</li>
</region>
<settlement><li>Winnipeg</li>
</settlement>
<orgName><li>Université du Manitoba</li>
</orgName>
</list>
<tree><country name="Canada"><region name="Manitoba"><name sortKey="Sinclair, Christopher J D" sort="Sinclair, Christopher J D" uniqKey="Sinclair C" first="Christopher J. D." last="Sinclair">Christopher J. D. Sinclair</name>
</region>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
<name sortKey="Parkinson, Fiona E" sort="Parkinson, Fiona E" uniqKey="Parkinson F" first="Fiona E." last="Parkinson">Fiona E. Parkinson</name>
</country>
<country name="États-Unis"><region name="Ohio"><name sortKey="Krizanac Bengez, Ljiljana" sort="Krizanac Bengez, Ljiljana" uniqKey="Krizanac Bengez L" first="Ljiljana" last="Krizanac-Bengez">Ljiljana Krizanac-Bengez</name>
</region>
<name sortKey="Janigro, Damir" sort="Janigro, Damir" uniqKey="Janigro D" first="Damir" last="Janigro">Damir Janigro</name>
<name sortKey="Stanness, Kathe A" sort="Stanness, Kathe A" uniqKey="Stanness K" first="Kathë A." last="Stanness">Kathë A. Stanness</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003265 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003265 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:AEDC0F477A53B2E132B34A9E0AFA1BB767CE4611 |texte= Adenosine permeation of a dynamic in vitro blood–brain barrier inhibited by dipyridamole }}
This area was generated with Dilib version V0.6.29. |